L-thioproline

Identification

Generic Name
L-thioproline
DrugBank Accession Number
DB02846
Background

Not Available

Type
Small Molecule
Groups
Experimental
Structure
Weight
Average: 133.169
Monoisotopic: 133.019749163
Chemical Formula
C4H7NO2S
Synonyms
  • (4R)-4-Thiazolidinecarboxylic acid
  • (R)-(-)-4-Thiazolidinecarboxylic acid
  • (R)-4-Thiazolidinecarboxylic acid
  • 4-thiaproline
  • L-thiaproline
  • L-Thiazolidine-4-carboxylic acid
  • Thiazolidinecarboxylic acid
  • γ-thioproline

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
TargetActionsOrganism
UAnnexin A5Not AvailableHumans
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Categories

Drug Categories
Not Available
Chemical TaxonomyProvided by Classyfire
Description
This compound belongs to the class of organic compounds known as l-alpha-amino acids. These are alpha amino acids which have the L-configuration of the alpha-carbon atom.
Kingdom
Organic compounds
Super Class
Organic acids and derivatives
Class
Carboxylic acids and derivatives
Sub Class
Amino acids, peptides, and analogues
Direct Parent
L-alpha-amino acids
Alternative Parents
Thiazolidines / Amino acids / Thiohemiaminal derivatives / Monocarboxylic acids and derivatives / Dialkylthioethers / Dialkylamines / Carboxylic acids / Azacyclic compounds / Organopnictogen compounds / Organic oxides
show 2 more
Substituents
Aliphatic heteromonocyclic compound / Amine / Amino acid / Azacycle / Carbonyl group / Carboxylic acid / Dialkylthioether / Hemithioaminal / Hydrocarbon derivative / L-alpha-amino acid
show 12 more
Molecular Framework
Aliphatic heteromonocyclic compounds
External Descriptors
thiazolidinemonocarboxylic acid, thioproline (CHEBI:45171)
Affected organisms
Not Available

Chemical Identifiers

UNII
KL096K0KXL
CAS number
2756-91-4
InChI Key
DZLNHFMRPBPULJ-VKHMYHEASA-N
InChI
InChI=1S/C4H7NO2S/c6-4(7)3-1-8-2-5-3/h3,5H,1-2H2,(H,6,7)/t3-/m0/s1
IUPAC Name
(4R)-1,3-thiazolidine-4-carboxylic acid
SMILES
[H][C@]1(CSCN1)C(O)=O

References

General References
Not Available
PubChem Compound
93176
PubChem Substance
46508931
ChemSpider
84120
BindingDB
50357232
ChEBI
45171
ChEMBL
CHEMBL1235440
ZINC
ZINC000000967473
PDBe Ligand
PRS
PDB Entries
1sav / 2ww7 / 5ff3 / 5uu2 / 5uu4 / 6xp2

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Solid
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility84.0 mg/mLALOGPS
logP-2.5ALOGPS
logP-2.7Chemaxon
logS-0.2ALOGPS
pKa (Strongest Acidic)2.59Chemaxon
pKa (Strongest Basic)7.7Chemaxon
Physiological Charge0Chemaxon
Hydrogen Acceptor Count3Chemaxon
Hydrogen Donor Count2Chemaxon
Polar Surface Area49.33 Å2Chemaxon
Rotatable Bond Count1Chemaxon
Refractivity30.82 m3·mol-1Chemaxon
Polarizability12.47 Å3Chemaxon
Number of Rings1Chemaxon
Bioavailability1Chemaxon
Rule of FiveYesChemaxon
Ghose FilterNoChemaxon
Veber's RuleNoChemaxon
MDDR-like RuleNoChemaxon
Predicted ADMET Features
PropertyValueProbability
Human Intestinal Absorption+0.9058
Blood Brain Barrier+0.8638
Caco-2 permeable-0.5897
P-glycoprotein substrateSubstrate0.5362
P-glycoprotein inhibitor INon-inhibitor0.9812
P-glycoprotein inhibitor IINon-inhibitor0.9949
Renal organic cation transporterNon-inhibitor0.8611
CYP450 2C9 substrateNon-substrate0.9076
CYP450 2D6 substrateNon-substrate0.7776
CYP450 3A4 substrateNon-substrate0.7665
CYP450 1A2 substrateNon-inhibitor0.8313
CYP450 2C9 inhibitorNon-inhibitor0.9219
CYP450 2D6 inhibitorNon-inhibitor0.9242
CYP450 2C19 inhibitorNon-inhibitor0.8693
CYP450 3A4 inhibitorNon-inhibitor0.9832
CYP450 inhibitory promiscuityLow CYP Inhibitory Promiscuity0.9804
Ames testNon AMES toxic0.9132
CarcinogenicityNon-carcinogens0.9319
BiodegradationReady biodegradable0.5445
Rat acute toxicity2.1981 LD50, mol/kg Not applicable
hERG inhibition (predictor I)Weak inhibitor0.9724
hERG inhibition (predictor II)Non-inhibitor0.95
ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397)

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSsplash10-001i-1900000000-507b6abf5b80f2370737
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSsplash10-001i-9000000000-6103f78feab98bdf47a5
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSsplash10-0apv-9400000000-bffea0e092e6e0f904b8
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSsplash10-001i-9000000000-45286d59c4a7ca5d4a4a
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSsplash10-001i-9000000000-8687eda0c09cb27ec253
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSsplash10-0a4j-9000000000-19ecb08cafb96ee6276e
Predicted 1H NMR Spectrum1D NMRNot Applicable
Predicted 13C NMR Spectrum1D NMRNot Applicable
Chromatographic Properties
Collision Cross Sections (CCS)
AdductCCS Value (Å2)Source typeSource
[M-H]-120.0338541
predicted
DarkChem Lite v0.1.0
[M-H]-122.50085
predicted
DeepCCS 1.0 (2019)
[M+H]+121.1569541
predicted
DarkChem Lite v0.1.0
[M+H]+125.37031
predicted
DeepCCS 1.0 (2019)
[M+Na]+120.2298541
predicted
DarkChem Lite v0.1.0
[M+Na]+134.34032
predicted
DeepCCS 1.0 (2019)

Targets

Build, predict & validate machine-learning models
Use our structured and evidence-based datasets to unlock new
insights and accelerate drug research.
Learn more
Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.
Learn more
Kind
Protein
Organism
Humans
Pharmacological action
Unknown
General Function
Phospholipid binding
Specific Function
This protein is an anticoagulant protein that acts as an indirect inhibitor of the thromboplastin-specific complex, which is involved in the blood coagulation cascade.
Gene Name
ANXA5
Uniprot ID
P08758
Uniprot Name
Annexin A5
Molecular Weight
35936.375 Da
References
  1. Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [Article]
  2. Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [Article]
  3. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article]

Drug created at June 13, 2005 13:24 / Updated at June 12, 2020 16:52